<DOC>
	<DOCNO>NCT01640067</DOCNO>
	<brief_summary>Primary aim trial 1. verify safety tolerability expand human fetal neural stem cell 2. verify safety tolerability microsurgery human fetal neural stem cell transplantation model 3. recognize change patient 's quality life Secondary aim trial 1. assessment impact human neural stem cell transplantation disability ALS clinically significant measurable way 2 . Assessment impact human neural stem cell transplantation mortality ( cause )</brief_summary>
	<brief_title>Human Neural Stem Cell Transplantation Amyotrophic Lateral Sclerosis ( ALS )</brief_title>
	<detailed_description>18 patient diagnose definite ALS accord El Escorial criterion recruit two year . The patient divide 3 group different severity . Each group less compromise group go . Their breathing measurement must least 60 % . Subjects receive injection human foetal neural stem cell spinal cord . A variety test examination take place every month first year every three month next two order monitor course disease adverse event .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Diagnosis definite possible ALS accord revise EL Escorial criterion Age : 2075 year document progression disease last 6 month . Absence concomitant disease Adequate assurance adherence protocol The patient must able communicate verbally use nonverbal communication system Group 1 maximum score 1 walk item ALS functional rating scale force vital capacity &gt; equal 60 Group 2 force vital capacity &gt; equal 60 ambulation difficulty ( maximum score 2 walk item ALS functional rating scale ) Group 3 Independent ambulation ( score 4 scale ALSFRS ) force vital capacity &gt; equal 70 The presence least one follow lead patient exclusion . 1. psychiatric disease neurological disease different ALS 2. systemic disease 3 . Neoplasms diseases reduce life expectancy 4 . Antecedent polio infection 5. corticosteroid , immunoglobulin immunosuppressive treatment 6. involvement clinical trial 7 . 2 critical item MMPI 8. neuropsychological evaluation suggestive mental deterioration cognitive sphere disturbance . 9 . Impediments MRI 10. patient unable understand inform consent form study aim . 11. woman pregnant childbearing potential duration study . Nonpregnant status document betaHCG negative test 7 day treatment start</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>amyotrophic lateral sclerosis</keyword>
	<keyword>motor neuron disease</keyword>
	<keyword>stem cell</keyword>
	<keyword>safety</keyword>
	<keyword>ALS-FRS-Functional scale R FVC ( % ) variation</keyword>
	<keyword>Survival analysis</keyword>
	<keyword>Changes quality life scale</keyword>
</DOC>